Vertex Pharmaceuticals Inc (VRTX) Q4 2021 (USD): EPS 3.37 (exp. 3.30), Revenue 2.07bln (exp. 2.00bln)

Via Business Wire

26 Jan 2022 - 21:01- Equities- Source: Business Wire

Vertex Pharmaceuticals IncPharmaceuticals, Biotechnology & Life SciencesBiotechnologyBiotechnology (Group)VRTX.USEquitiesVRTXS&P 500 IndexNASDAQ 100 IndexAsian SessionUSDUnited States

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: